- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2195-9595
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Natural History of NAFLD/NASH ; volume:16 ; number:4 ; day:13 ; month:11 ; year:2017 ; pages:391-397 ; date:12.2017
Current hepatology reports ; 16, Heft 4 (13.11.2017), 391-397, 12.2017
- Creator
-
Ekstedt, Mattias
- Contributor
-
Nasr, Patrik
Kechagias, Stergios
SpringerLink (Online service)
- DOI
-
10.1007/s11901-017-0378-2
- URN
-
urn:nbn:de:1111-201802241497
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ekstedt, Mattias
- Nasr, Patrik
- Kechagias, Stergios
- SpringerLink (Online service)
Other Objects (12)
The role of the microbiome in NAFLD and NASH
Current and future pharmacological therapies for NAFLD/NASH
Pharmacological inhibition of mINDY for the treatment of NAFLD/NASH
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
Lebens- und Schlafqualität bei Patienten mit einer Nicht-Alkoholischen-Fettleber (NAFLD) in Abhängigkeit der Leberfunktion – eine LiMax-NAFLD/NASH-Studie
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
Non-invasive detection of fibrotic NASH in NAFLD patients with low or intermediate FIB-4
The role of the microbiome in NAFLD and NASH
Current and future pharmacological therapies for NAFLD/NASH
Pharmacological inhibition of mINDY for the treatment of NAFLD/NASH
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
Lebens- und Schlafqualität bei Patienten mit einer Nicht-Alkoholischen-Fettleber (NAFLD) in Abhängigkeit der Leberfunktion – eine LiMax-NAFLD/NASH-Studie
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
Non-invasive detection of fibrotic NASH in NAFLD patients with low or intermediate FIB-4
The role of the microbiome in NAFLD and NASH
Current and future pharmacological therapies for NAFLD/NASH
Pharmacological inhibition of mINDY for the treatment of NAFLD/NASH
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
Lebens- und Schlafqualität bei Patienten mit einer Nicht-Alkoholischen-Fettleber (NAFLD) in Abhängigkeit der Leberfunktion – eine LiMax-NAFLD/NASH-Studie
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future